Stronger Atropine Eye Drops Slow Severe Nearsightedness in Children, Trial Finds
A two-year randomized controlled trial in Shanghai found that nightly 0.10 percent atropine eye drops significantly slowed myopia progression in ...
A two-year randomized controlled trial in Shanghai found that nightly 0.10 percent atropine eye drops significantly slowed myopia progression in ...
A randomized trial combining in situ viral imaging and mass spectrometry shows that first-line dolutegravir/lamivudine therapy penetrates lymph node tissue ...
A controversial clinical trial has once again thrust homeopathy into the center of a scientific firestorm. In a prospective, randomized, ...
A phase 2 trial found that ultra-low-dose radiation therapy delivered in one or two sessions relieved painful bone lesions in ...
Five-year results from the NRG-GU003 Phase III trial show that a 25-fraction, five-week postoperative radiation schedule achieved biochemical control and ...
A randomized controlled trial published in Nature Communications reports that the oral CDK7 inhibitor samuraciclib combined with fulvestrant improved clinical ...
UChicago Medicine has launched a first-of-its-kind investigator-initiated clinical trial of a fully on-site manufactured T-cell receptor therapy engineered to target ...
A seven-year prospective trial shows that oral S-1 plus cisplatin preserves overall 5-FU exposure and manageable toxicity in cancer patients ...
A double-blind crossover trial in 15 healthy volunteers found that intravenous apelin-13, at both high and low doses, did not ...
A multicenter Chinese trial reports that a novel asymmetric biphasic pulsed field ablation system achieved complete acute pulmonary vein isolation ...
A randomized placebo-controlled trial in Tunisia found that quercetin–bromelain supplementation significantly reduced respiratory deterioration in hospitalized COVID-19 patients, though mortality ...
A randomized crossover fMRI trial shows that lowering the potent androgen DHT with finasteride alters temporal brain activation during response ...
A widely used lactation-suppressing drug, cabergoline, was linked to a sharply lower postpartum breast cancer risk in women and halved ...
A prospective Chinese study found that adding the immunotherapy drug camrelizumab to induction chemotherapy before concurrent chemoradiotherapy produced high complete ...
A prospective controlled study in BMC Medicine found that adding hepatic arterial infusion chemotherapy to lenvatinib and a PD-1 inhibitor ...
A prospective Canadian pilot study found that FET-PET/MRI revealed significantly larger metabolically active tumor volumes than conventional MRI in more ...
A randomised double-blind trial shows the potassium binder sodium zirconium cyclosilicate enabled twice as many patients with chronic kidney disease ...
Keck Medicine of USC has launched an early-phase clinical trial testing CX-011, a single-injection investigational therapy designed to modulate GP130 ...
A phase I trial at Ohio State found that CAR T cells engineered to target three B-cell proteins and boosted ...
For the first time, six proteomic aging clocks have been deployed as readouts in a clinical trial, revealing more about ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.